Page last updated: 2024-08-20

dextrothyroxine and Neoplasms

dextrothyroxine has been researched along with Neoplasms in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's0 (0.00)18.2507
2000's1 (10.00)29.6817
2010's4 (40.00)24.3611
2020's4 (40.00)2.80

Authors

AuthorsStudies
Steckel, S; Valentine, AS; Weintraub, M1
Azeredo, FJ; de Melo Soares, D; Dos Santos Silva, ACS; Estrela-Lima, A; Godoy, ALPC; Hlavac, N; Machado, MCA; Neves, FMF; Silva, LP; Yamamoto, PA1
Cheng, L; Liu, J; Xu, T; Zhang, K; Zhu, H1
Alarcon, S; Chávez, S; Díaz, R; García, J; Gutierrez, C; Hernandez, E; León, E; Maradiegue, E; Maza, I; Montoya, J; Moore, C; Morales, R; Ordoñez, K; Reaño, R; Rojas, N; Sanchez, K; Ugaz, C; Valdiviezo, C; Vargas, MP; Vásquez, L; Zapata, A1
Cheng, F; Fang, Q; Hu, X; Li, J; Tang, M; Wang, Y; Yao, X; Yu, C; Zhang, W1
Huczyński, A; Kaysiewicz, J; Markowska, A; Markowska, J1
Jiang, L; Sun, YJ; Wang, P; Wu, YJ1
Borges, I; Kuciak, M; Lorente-Trigos, A; Mas, C; Melotti, A; Ruiz i Altaba, A1
Gatter, KC; Giatromanolaki, A; Harris, AL; Kalamida, D; Koukourakis, MI; Mitrakas, A; Pouliliou, S; Sivridis, E; Zois, CE1
Boussinesq, M; Duke, BO; Gardo, J; Kamgno, J; Marty, AM; Peett, DL; Pion, SD1

Reviews

3 review(s) available for dextrothyroxine and Neoplasms

ArticleYear
Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin.
    Drug design, development and therapy, 2020, Volume: 14

    Topics: Antineoplastic Agents; Cell Death; Cell Proliferation; Humans; Ivermectin; Mitochondria; Neoplasms; Neovascularization, Pathologic; Oxidative Stress

2020
Ivermectin, a potential anticancer drug derived from an antiparasitic drug.
    Pharmacological research, 2021, Volume: 163

    Topics: Animals; Antineoplastic Agents; Antiparasitic Agents; Cell Death; Humans; Ivermectin; Molecular Targeted Therapy; Neoplasms; Signal Transduction

2021
Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs.
    Bioorganic & medicinal chemistry letters, 2019, 07-01, Volume: 29, Issue:13

    Topics: Antineoplastic Agents; Doxycycline; Humans; Ivermectin; Monensin; Neoplasms; Pyrans

2019

Trials

2 trial(s) available for dextrothyroxine and Neoplasms

ArticleYear
Pain relief for cancer patients.
    The American journal of nursing, 1978, Volume: 78, Issue:12

    Topics: Chloroform; Clinical Trials as Topic; Cocaine; Dextrothyroxine; Drug Combinations; Drug Evaluation; Ethanol; Humans; Methadone; Neoplasms; Pain, Intractable; Phenothiazines

1978
Neoplastic change in Onchocerca volvulus and its relation to ivermectin treatment.
    Parasitology, 2002, Volume: 125, Issue:Pt 5

    Topics: Adult; Aging; Animals; Anthelmintics; Cameroon; Female; Humans; Ivermectin; Male; Middle Aged; Neoplasms; Odds Ratio; Onchocerca volvulus; Onchocerciasis; Prevalence

2002

Other Studies

5 other study(ies) available for dextrothyroxine and Neoplasms

ArticleYear
A pilot study of chemotherapy combinations in rats: Focus on mammary cancer treatment in female dogs.
    Research in veterinary science, 2023, Volume: 156

    Topics: Animals; Carboplatin; Cyclophosphamide; Dog Diseases; Dogs; Female; Ivermectin; Neoplasms; Pilot Projects; Rats; Rats, Wistar; Rodent Diseases

2023
COVID-19 in pediatric cancer patients in a resource-limited setting: National data from Peru.
    Pediatric blood & cancer, 2021, Volume: 68, Issue:2

    Topics: Adolescent; Adrenal Cortex Hormones; Antiviral Agents; Azithromycin; Child; Child, Preschool; COVID-19; COVID-19 Drug Treatment; Female; Humans; Infant; Ivermectin; Male; Neoplasms; Palliative Care; Peru; SARS-CoV-2; Treatment Outcome

2021
Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway.
    Journal of experimental & clinical cancer research : CR, 2019, Jun-18, Volume: 38, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Doxorubicin; Drug Repositioning; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Female; HCT116 Cells; Humans; Ivermectin; K562 Cells; MAP Kinase Signaling System; MCF-7 Cells; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Neoplasms; NF-kappa B; Proto-Oncogene Proteins c-akt; Vincristine

2019
The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer.
    EMBO molecular medicine, 2014, Volume: 6, Issue:10

    Topics: Animals; Apoptosis; beta Catenin; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Female; HEK293 Cells; HT29 Cells; Humans; Immunohistochemistry; Insecticides; Ivermectin; Lactones; Macrocyclic Compounds; Mice, Inbred Strains; Mice, Nude; Mutation; Neoplasms; Onchocerciasis, Ocular; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; TCF Transcription Factors; Wnt Proteins; Xenograft Model Antitumor Assays

2014
Autophagosome Proteins LC3A, LC3B and LC3C Have Distinct Subcellular Distribution Kinetics and Expression in Cancer Cell Lines.
    PloS one, 2015, Volume: 10, Issue:9

    Topics: Active Transport, Cell Nucleus; Antibodies; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Line, Tumor; Fatty Acids, Unsaturated; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Ivermectin; Macrolides; Membrane Proteins; Microtubule-Associated Proteins; Neoplasms; RNA Interference; RNA, Small Interfering

2015